Emily G Greengard (Emily Greengard)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Advanced Non Small Cell Lung Cancer

Top Venues

Pediatric blood & cancer

Children (Basel, Switzerland)

Cancer chemotherapy and pharmacology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Emily G Greengard, Robin Williams, Branden Moriarity, Xiaowei Liu, Charles G Minard, Joel M Reid, Terrence Fisher, Elizabeth Evans, Desa Rae Pastore, Maurice Zauderer, Stephan D Voss, Elizabeth Fox, Brenda J Weigel
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614). Pediatric blood & cancer 71 (6) (2024)
Emily G Greengard, Robin Williams, Branden Moriarity, Xiaowei Liu, Charles G Minard, Joel M Reid, Terrence Fisher, Elizabeth Evans, Desa Rae Pastore, Maurice Zauderer, Stephan D Voss, Elizabeth Fox, Brenda J Weigel
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614). Pediatric blood & cancer 71 (6) (2024)
Emily G Greengard, Robin Williams, Branden Moriarity, Xiaowei Liu, Charles G Minard, Joel M Reid, Terrence Fisher, Elizabeth Evans, Desa Rae Pastore, Maurice Zauderer, Stephan D Voss, Elizabeth Fox, Brenda J Weigel
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614). Pediatric blood & cancer 71 (6) (2024)
Emily G Greengard, Robin Williams, Branden Moriarity, Xiaowei Liu, Charles G Minard, Joel M Reid, Terrence Fisher, Elizabeth Evans, Desa Rae Pastore, Maurice Zauderer, Stephan D Voss, Elizabeth Fox, Brenda J Weigel
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614). Pediatric blood & cancer (2024)
Jerry Li, Lin Swan, Nickens Dana, Frank M Balis, Emily G Greengard, Xu Huiping
Population modeling analyses of crizotinib in pediatric patients with ALK-positive advanced cancers. Pediatric blood & cancer 71 (9) (2024)
Jerry Li, Lin Swan, Nickens Dana, Frank M Balis, Emily G Greengard, Xu Huiping
Population modeling analyses of crizotinib in pediatric patients with ALK-positive advanced cancers. Pediatric blood & cancer 71 (9) (2024)
Jerry Li, Lin Swan, Nickens Dana, Frank M Balis, Emily G Greengard, Xu Huiping
Population modeling analyses of crizotinib in pediatric patients with ALK-positive advanced cancers. Pediatric blood & cancer (2024)
Emily G Greengard, Robin Williams, Branden Moriarity, Xiaowei Liu, Charles G Minard, Joel M Reid, Terrence Fisher, Elizabeth Evans, Desa Rae Pastore, Maurice Zauderer, Stephan D Voss, Elizabeth Fox, Brenda J Weigel
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614). Pediatric blood & cancer 71 (6) (2024)
Emily G Greengard, Robin Williams, Branden Moriarity, Xiaowei Liu, Charles G Minard, Joel M Reid, Terrence Fisher, Elizabeth Evans, Desa Rae Pastore, Maurice Zauderer, Stephan D Voss, Elizabeth Fox, Brenda J Weigel
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614). Pediatric blood & cancer 71 (6) (2024)
Jerry Li, Lin Swan, Nickens Dana, Frank M Balis, Emily G Greengard, Xu Huiping
Population modeling analyses of crizotinib in pediatric patients with ALK-positive advanced cancers. Pediatric blood & cancer 71 (9) (2024)
Adam M Lee, Asmaa Ferdjallah, Elise Moore, Daniel C Kim, Aritro Nath, Emily G Greengard, Rong Stephanie Huang
Long Non-Coding RNA ANRIL as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma. International journal of molecular sciences 22 (20) (2021)
Emily G Greengard, Yael P Mosse, Xiaowei Liu, Charles G Minard, Joel M Reid, Stephan Voss, Keith Wilner, Elizabeth Fox, Frank Balis, Susan M Blaney, Peter C Adamson, Brenda J Weigel
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212). Cancer chemotherapy and pharmacology 86 (6) (2020)
Emily G Greengard
Molecularly Targeted Therapy for Neuroblastoma. Children (Basel, Switzerland) 5 (10) (2018)